Can virtual care reduce treatment burden in pediatric leukemia? A retrospective cost analysis by Dreher, Jonas, Meryk, Andreas, Riedl, David, Kropshofer, Gabriele, Hetzer, Benjamin, Neururer, Sabrina, Pfeifer, Bernhard, Schneeberger‐Carta, Verena, Holzner, Bernhard, Crazzolara, Roman

Get full text

Swarm Learning for decentralized and confidential clinical machine learning by Warnat-Herresthal, Stefanie, Schultze, Hartmut, Shastry, Krishnaprasad Lingadahalli, Manamohan, Sathyanarayanan, Mukherjee, Saikat, Garg, Vishesh, Sarveswara, Ravi, Händler, Kristian, Pickkers, Peter, Aziz, N. Ahmad, Ktena, Sofia, Tran, Florian, Bitzer, Michael, Ossowski, Stephan, Casadei, Nicolas, Herr, Christian, Petersheim, Daniel, Behrends, Uta, Kern, Fabian, Fehlmann, Tobias, Schommers, Philipp, Lehmann, Clara, Augustin, Max, Rybniker, Jan, Altmüller, Janine, Mishra, Neha, Bernardes, Joana P., Krämer, Benjamin, Bonaguro, Lorenzo, Schulte-Schrepping, Jonas, De Domenico, Elena, Siever, Christian, Kraut, Michael, Desai, Milind, Monnet, Bruno, Saridaki, Maria, Siegel, Charles Martin, Drews, Anna, Nuesch-Germano, Melanie, Theis, Heidi, Heyckendorf, Jan, Schreiber, Stefan, Kim-Hellmuth, Sarah, Nattermann, Jacob, Skowasch, Dirk, Kurth, Ingo, Keller, Andreas, Bals, Robert, Nürnberg, Peter, Rieß, Olaf, Rosenstiel, Philip, Netea, Mihai G., Theis, Fabian, Mukherjee, Sach, Backes, Michael, Aschenbrenner, Anna C., Ulas, Thomas, Breteler, Monique M. B., Giamarellos-Bourboulis, Evangelos J., Kox, Matthijs, Becker, Matthias, Cheran, Sorin, Woodacre, Michael S., Goh, Eng Lim, Schultze, Joachim L.

Get full text

HLA-DQA105 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Coli... by Reppell, Mark, Zheng, Xiuwen, Dreher, Ingeborg, Blaes, Jonas, Regan, Elina, Haslberger, Tobias, Guay, Heath, Pivorunas, Valerie, Smaoui, Nizar

Get full text

Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn’s Disease and Ulc... by Ponce-Bobadilla, Ana Victoria, Stodtmann, Sven, Chen, Mong-Jen, Winzenborg, Insa, Mensing, Sven, Blaes, Jonas, Haslberger, Tobias, Laplanche, Loic, Dreher, Ingeborg, Mostafa, Nael M.

Get full text

HLA-DQA105 associates with anti-TNF immunogenicity and low adalimumab trough concentrations in inflammatory bowel disease patients from the SERENE UC and CD studies by Reppell, Mark, Zheng, Xiuwen, Dreher, Ingeborg, Blaes, Jonas, Regan, Elina, Haslberger, Tobias, Guay, Heath, Pivorunas, Valerie, Smaoui, Nizar

Get full text

Urodynamik by Leisner, B., Koch, J., Mayr, B., Moser, E. A., Faber, P., Deck, H. J., Herberger, J., Schmidt, H., Heidenreich, J., Grüneberger, A., Geier, G., Eberhard, J., Krajnović, P., Oberhofer, S., Zubec, Z., Würth, K., Dreher, E., Eduah, S. B., Adam, P., Fischer, B., Schmidt-Rimpler, J., Articus, M., Staufer, F., Lochmüller, H., Lienhard, P., Furrer, M., Kümper, H. J., Richter, K., Pickart, M., Heinz, F., Jonas, U., Petri, E., Adam, P. J., Koutifaris, B., Nestoridis, N., Christodoulakos, G., Kalogirou, D., Altmann, P., Tammen, H., Krieglsteiner, P., Achhammer, I., Graatz, B., Parache, J., Gonzales Chavez, G., Zerolo, J. M., Fdez Robayana, F., Ojeda, A., Cotter, A.

Get full text